Brief
DermaSensor as an adjunctive diagnostic tool for lesions suspicious for skin cancer
Condition
Cancer
30 April 2026
Published on 30 Apr 2026
Last Updated on 30 Apr 2026
This Horizon Scanning Brief provides an assessment of DermaSensor to evaluate skin lesions suggestive of melanoma, basal cell carcinoma, and/or squamous cell carcinoma in patients aged 40 and above to assist in the decision regarding referral of the patient to a dermatologist.
DermaSensor as an adjunctive diagnostic tool for lesions suspicious for skin cancer
